Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons

Psychopharmacology

Volumn 180, Issue 2, 2005, Pages 342-351

  Goodwin, Amy K ^a   Froestl, Wolfgang ^b   Weerts, Elise M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Ataxia; Conditioned performance; Feeding; Operant behavior; Reinforcement schedule; Xyrem

Indexed keywords

3 AMINOPROPYLBUTYLPHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 HYDROXYBUTYRIC ACID; 5 HYDROXY 5,7,8,9 TETRAHYDRO 6H BENZO[A][7]ANNULEN 6 YLIDENE ETHANOIC ACID; BENZENE DERIVATIVE; NCS 382; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ATAXIA; BABOON; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE RESPONSE; FEEDING BEHAVIOR; FOOD; GASTROINTESTINAL DISEASE; INSTRUMENTAL CONDITIONING; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REINFORCEMENT; SEDATION; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE;

ANIMALS; BEHAVIOR, ANIMAL; BENZOCYCLOHEPTENES; MALE; ORGANOPHOSPHORUS COMPOUNDS; PAPIO; RECEPTORS, GABA-B; SODIUM OXYBATE;

EID: 21344449082     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-2165-y     Document Type: Article

References (42)

1. Barker SA, Snead OC, Poldrugo F, Liu CC, Fish FP, Settine RL (1985) Identification and quantitation of 1,4-butanediol in mammalian tissues: an alternative biosynthetic pathway for gamma-hydroxybutyric acid. Biochem Pharmacol 34:1849-1852
2. Borgen LA, Cook HN, Hornfeldt CS, Fuller DE (2002) Sodium oxybate (GHB) for treatment of cataplexy. Pharmacotherapy 22:798-799 (discussion 799)
3. Borgen LA, Okerholm RA, Lai A, Scharf MB (2004) The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients. J Clin Pharmacol 44:253-257
4. Carai MA, Colombo G, Brunetti G, Melis S, Serra S, Vacca G, Mastinu S, Pistuddi AM, Solinas C, Cignarella G, Minardi G, Gessa GL (2001) Role of GABA(B) receptors in the sedative/ hypnotic effect of gamma-hydroxybutyric acid. Eur J Pharmacol 428:315-321
5. Carter LP, Flores LR, Wu H, Chen W, Unzeitig AW, Coop A, France CP (2003) The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies. J Pharmacol Exp Ther 305:668-674
6. Carter LP, Wu H, Chen W, Cruz CM, Lamb RJ, Koek W, Coop A, France CP (2004) Effects of gamma-hydroxybutyrate (GHB) on schedule-controlled responding in rats: role of GHB and GABA-B receptors. J Pharmacol Exp Ther 308:182-188
7. Castelli MP, Mocci I, Pistis M, Peis M, Berta D, Gelain A, Gessa GL, Cignarella G (2002) Stereoselectivity of NCS-382 binding to gamma- hydroxybutyrate receptor in the rat brain. Eur J Pharmacol 446:1-5
8. Colombo G, Agabio R, Bourguignon J, Fadda F, Lobina C, Maitre M, Reali R, Schmitt M, Gessa GL (1995) Blockade of the discriminative stimulus effects of gamma-hydroxybutyric acid (GHB) by the GHB receptor antagonist NCS-382. Physiol Behav 58: 587-590
9. Colombo G, Agabio R, Lobina C, Reali R, Gessa GL (1998) Involvement of GABA(A) and GABA(B) receptors in the mediation of discriminative stimulus effects of gamma-hydroxybutyric acid. Physiol Behav 64:293-302
10. Cook CD, Aceto MD, Coop A, Beardsley PM (2002) Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice. Psychopharmacology (Berl) 160:99-106
11. Doherty JD, Stout RW, Roth RH (1975) Metabolism of (1-14C) gamma-hydroxybutyric acid by rat brain after intraventricular injection. Biochem Pharmacol 24:469-474
12. Froestl W, Gallagher M, Jenkins H, Madrid A, Melcher T, Teichman S, Mondadori CG, Pearlman R (2004) SGS742: the first GABA (B) receptor antagonist in clinical trials. Biochem Pharmacol 68:1479-1487
13. Galloway GP, Frederick SL, Staggers FE, Gonzales M, Stalcup SA, Smith DE (1997) Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 92:89-96
14. Galloway GP, Frederick-Osborne SL, Seymour R, Contini SE, Smith DE (2000) Abuse and therapeutic potential of gamma-hydroxybutyric acid. Alcohol 20:263-269
15. Itzhak Y, Ali SF (2002) Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB. Ann N Y Acad Sci 965:451-460
16. Kaupmann K, Cryan JF, Wellendorph P, Mombereau C, Sansig G, Klebs K, Schmutz M, Froestl W, van der Putten H, Mosbacher J, Brauner-Osborne H, Waldmeier P, Bettler B (2003) Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice. Eur J Neurosci 18:2722-2730
17. Lamb RJ, Munn J, Duiker NJ, Coop A, Wu H, Koek W, France CP (2003) Interactions of gamma-hydroxy butyrate with ethanol and NCS 382. Eur J Pharmacol 470:157-162
18. Lingenhoehl K, Brom R, Heid J, Beck P, Froestl W, Kaupmann K, Bettler B, Mosbacher J (1999) Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors. Neuropharmacology 38:1667-1673
19. Lobina C, Agabio R, Reali R, Gessa GL, Colombo G (1999) Contribution of GABA(A) and GABA(B) receptors to the discriminative stimulus produced by gamma-hydroxybutyric acid. Pharmacol Biochem Behav 64:363-365
20. Lukas SE, Griffiths RR (1984) Precipitated diazepam withdrawal in baboons: effects of dose and duration of diazepam exposure. Eur J Pharmacol 100:163-171
21. Lukas SE, Griffiths RR, Bradford LD, Brady JV, Daley L (1982) A tethering system for intravenous and intragastric drug administration in the baboon. Pharmacol Biochem Behav 17:823-829
22. Maitre M, Hechler V, Vayer P, Gobaille S, Cash CD, Schmitt M, Bourguignon JJ (1990) A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties. J Pharmacol Exp Ther 255:657-663
23. Maitre M, Andriamampandry C, Kemmel V, Schmidt C, Hode Y, Hechler V, Gobaille S (2000) Gamma-hydroxybutyric acid as a signaling molecule in brain. Alcohol 20:277-283
24. Mathivet P, Bernasconi R, De Barry J, Marescaux C, Bittiger H (1997) Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist. Eur J Pharmacol 321:67-75
25. 3H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo [α][7]annulen-6- ylidene) ethanoic acid in the rat brain. J Pharmacol Exp Ther 299:1148-1153
26. Miotto K, Darakjian J, Basch J, Murray S, Zogg J, Rawson R (2001) Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. Am J Addict 10:232-241
27. Navarro JF, Pedraza C, Martin M, Manzaneque JM, Davila G, Maldonado E (1998) Tiapride-induced catalepsy is potentiated by gamma-hydroxybutyric acid administration. Prog Neuro-Psychopharmacol Biol Psychiatry 22:835-844
28. Nicholson KL, Balster RL (2001) GHB: a new and novel drug of abuse. Drug Alcohol Depend 63:1-22
29. Nissbrandt H, Engberg G (1996) The GABAB-receptor antagonist, CGP 35348, antagonises gamma-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice. J Neural Transm 103:1255-1263
30. Palatini P, Tedeschi L, Frison G, Padrini R, Zordan R, Orlando R, Gallimberti L, Gessa GL, Ferrara SD (1993) Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. Eur J Clin Pharmacol 45:353-356
31. Sannerud CA, Allen M, Cook JM, Griffiths RR (1991) Behavioral effects of benzodiazepine ligands in non-dependent, diazepam-dependent and diazepam-withdrawn baboons. Eur J Pharmacol 202:159-169
32. Schmidt C, Gobaille S, Hechler V, Schmitt M, Bourguignon JJ, Maitre M (1991) Anti-sedative and anti-cataleptic properties of NCS-382, a gamma-hydroxybutyrate receptor antagonist. Eur J Pharmacol 203:393-397
33. Schwartz RH, Milteer R, LeBeau MA (2000) Drug-facilitated sexual assault ('date rape'). South Med J 93:558-561
34. Serra M, Sanna E, Foddi C, Concas A, Biggio G (1991) Failure of gamma-hydroxybutyrate to alter the function of the GABAA receptor complex in the rat cerebral cortex. Psychopharmacology 104:351-355
35. Sevak RJ, France CP, Koek W (2004) Neuroleptic-like effects of γ-hydroxybutyrate: interactions with haloperidol and dizocilpine. Eur J Pharmacol 483:289-293
36. Sidman M (1960) Tactics of scientific research. Basic Books, New York, NY
37. Snead OC (1978) Gamma hydroxybutyrate in the monkey. I. Electroencephalographic, behavioral, and pharmacokinetic studies. Neurology 28:636-642
38. Snead OC III (1988) Gamma-hydroxybutyrate model of generalized absence seizures: further characterization and comparison with other absence models. Epilepsia 29:361-368
39. Snead OC (1996) Antiabsence seizure activity of specific GABA-B and gamma-hydroxybutyric acid receptor antagonists. Pharmacol Biochem Behav 53:73-79
40. Weerts EM, Griffiths RR (1999) Evaluation of limited and unlimited feeding during withdrawal in triazolam-dependent baboons. Behav Pharmacol 10:415-421
41. Weerts EM, Ator NA, Grech DM, Griffiths RR (1998) Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. J Pharmacol Exp Ther 285:41-53
42. Winters WD, Spooner CE (1965) A neurophysiological comparison of gamma-hydroxybutyrate with pentobarbital in cats. Electroencephalogr Clin Neurophysiol 18:287-296